BCL10 Antikörper
-
- Target Alle BCL10 Antikörper anzeigen
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BCL10 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human BCL10 (NP_003912) produced in HEK293T cell.
- Klon
- 4A8
- Isotyp
- IgG1
- Top Product
- Discover our top product BCL10 Primärantikörper
-
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-143) antibody
BCL10 Reaktivität: Human WB, FACS, IHC (p) Wirt: Maus Monoclonal 1185CT13-2-1-2 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Maus WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 4F8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 24-51), (N-Term) antibodyBCL10 Reaktivität: Human, Maus WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB24271 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 98-234) antibodyBCL10 Reaktivität: Human WB, IHC, ELISA, FACS, ICC, Neut Wirt: Maus Monoclonal 3C11F4 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reaktivität: Human IHC, IF, FACS, StM Wirt: Kaninchen Monoclonal BL10-2988R unconjugated Recombinant Antibody
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reaktivität: Human WB, IHC, FACS, StM Wirt: Maus Monoclonal BL10-411 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Hund WB, IHC, IHC (p) Wirt: Maus Monoclonal 6A8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-233) antibodyBCL10 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Maus WB, IF, IHC (p), EIA Wirt: Maus Monoclonal 4F8 unconjugated
-
- Applikationshinweise
- WB 1:2000, IHC 1:50, IF 1:100, FLOW 1:100
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
- Target
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
- Andere Bezeichnung
- BCL10 (BCL10 Produkte)
- Synonyme
- CARMEN antikoerper, CIPER antikoerper, CLAP antikoerper, c-E10 antikoerper, mE10 antikoerper, BCL10 antikoerper, AI132454 antikoerper, BCL-10 antikoerper, C81403 antikoerper, ME10 antikoerper, cE10 antikoerper, bcl10 antikoerper, B-cell CLL/lymphoma 10 antikoerper, B-cell lymphoma/leukemia 10-like antikoerper, B cell leukemia/lymphoma 10 antikoerper, B-cell lymphoma/leukemia 10 antikoerper, BCL10 antikoerper, Bcl10 antikoerper, bcl10 antikoerper, LOC100223183 antikoerper
- Molekulargewicht
- 26.1 kDa
- Gen-ID
- 8915
- NCBI Accession
- NM_003921
- HGNC
- 8915
- Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
-
